Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient RegistryTake-home Points

Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient RegistryTake-home Points

Background: Patients with idiopathic pulmonary fibrosis (IPF) experience debilitating symptoms. Although antifibrotics may slow lung function decline, their impact on patients’ health-related quality of life and disease symptoms in the real world remains unknown. Research Question: What is the impac...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohleen Kang, MD, MS, Sachin Gupta, MD, Yi-Hsuan Tu, PhD, Karina Raimundo, MS, Anisha M. Patel, PhD, Kevin R. Flaherty, MD
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:CHEST Pulmonary
Subjects:
antifibrotic therapy
IPF
patient-reported outcomes
pirfenidone
quality of life
Online Access:http://www.sciencedirect.com/science/article/pii/S2949789224000485
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2949789224000485

Similar Items